Highlights and Quick Summary
- Net Income for the quarter ending February 28, 2023 was $-5.56 Million (a -240.45% decrease compared to previous quarter)
- Year-over-year quarterly Net Income increased by 152.95%
- Annual Net Income for 2022 was $-11.2 Million (a -89.11% decrease from previous year)
- Annual Net Income for 2021 was $-103 Million (a 1.78% increase from previous year)
- Annual Net Income for 2020 was $-101 Million (a 1312.87% increase from previous year)
- Twelve month Net Income ending February 28, 2023 was $-8.62 Million (a 38.24% increase compared to previous quarter)
- Twelve month trailing Net Income decreased by -66.76% year-over-year
Trailing Net Income for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| $-8.62 Million | $-6.24 Million | $-11.2 Million | $-25.9 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Income of Organigram Holdings Inc.
Most recent Net Incomeof OGI including historical data for past 10 years.Interactive Chart of Net Income of Organigram Holdings Inc.
Organigram Holdings Inc. Net Income for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-5.56 | – | – | – | – |
| 2022 | $3.96 | $-4.82 | $-2.2 | $-3.17 | $-11.23 |
| 2021 | $-1.04 | $-19.53 | $-4.53 | $-52.95 | $-103.09 |
| 2020 | $-26.08 | $-31.47 | $-63.98 | $-5.19 | $-101.29 |
| 2019 | $-0.65 | $-16.83 | $-7.7 | $-5.2 | $-7.17 |
| 2018 | – | – | $22.56 | $17.33 | $17.33 |
| 2017 | – | – | – | – | $0.0 |
| 2016 | – | – | – | – | $0.65 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic